US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 5, 2022 (5 years ago)

Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.

What was recalled

Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit forming, Preservative Free, Manufactured by Akorn, Inc. Lake Forest, IL 60045, NDC 17478-0050-02.

Recalling firm
Akorn, Inc.
NDC code
17478-0050-02
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0460-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Sufentanil recalls

See all